Evidence map›Paper›PMID 32250602›Full record

ArticleJournal of the American Chemical Society2020

Synthesis of β-Phenethylamines via Ni/Photoredox Cross-Electrophile Coupling of Aliphatic Aziridines and Aryl Iodides.

Talia J Steiman, Junyi Liu, Amanuella Mengiste, Abigail G Doyle

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Article
  2. Recyclable dual Z-scheme perovskite/g-CNature communications · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Vitamin BOrganic letters · 2025
    Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Talia J SteimanDepartment of Chemistry, Princeton University, Princeton, New Jersey 08544, United States.
Junyi LiuDepartment of Chemistry, Princeton University, Princeton, New Jersey 08544, United States.
Amanuella MengisteDepartment of Chemistry, Princeton University, Princeton, New Jersey 08544, United States.
Abigail G DoyleDepartment of Chemistry, Princeton University, Princeton, New Jersey 08544, United States.ORCID 0000-0002-6641-0833

Funding

New Directions in Nickel and Photoredox CatalysisR35GM126986 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Abigail Gutmann Doyle · 2018 to 2026
$3.7M
Visible Light Promoted Decarboxylative Trifluoromethylation for Application to PET ImagingF32EB027587 · NIBIB · PRINCETON UNIVERSITY · PI STEIMAN , TALIA · 2019 to 2019
$61k
NIBIB NIH HHS F32 EB027587NIGMS NIH HHS R35 GM126986
6 · The paper itself

Abstract

A photoassisted Ni-catalyzed reductive cross-coupling between tosyl-protected alkyl aziridines and commercially available (hetero)aryl iodides is reported. This mild and modular method proceeds in the absence of stoichiometric heterogeneous reductants and uses an inexpensive organic photocatalyst to access medicinally valuable β-phenethylamine derivatives. Unprecedented reactivity was achieved with the activation of cyclic aziridines. Mechanistic studies suggest that the regioselectivity and reactivity observed under these conditions are a result of nucleophilic iodide ring opening of the aziridine to generate an iodoamine as the active electrophile. This strategy also enables cross-coupling with Boc-protected aziridines.

Indexed as

AziridinesCatalysisHumansIodidesMolecular StructurePhenethylaminesStereoisomerismAziridinesIodidesphenethylaminePhenethylamines

Identifiers

PMID32250602
PMCPMC7457342

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.